First‐line programmed death receptor‐1 ( <scp>PD</scp> ‐1) inhibitor and epidermal growth factor receptor (EGFR) blockade, combined with platinum‐based chemotherapy, for stage <scp>IV</scp> penile cancer-Reference-Cited by-同舟云学术

First‐line programmed death receptor‐1 ( PD ‐1) inhibitor and epidermal growth factor receptor (EGFR) blockade, combined with platinum‐based chemotherapy, for stage IV penile cancer

Published:2022-07-07 Issue:2 Volume:131 Page:198-207
ISSN:1464-4096
Container-title:BJU International
language:en
Short-container-title:BJU International

Author:

Yan Ru¹²,Ma Huali²³,Jiang Lijuan¹²,Guo Shengjie¹²,Shi Yanxia²⁴,Sheng Xinan⁵,Zhang Yijun²⁶,Spiess Philippe E.⁷,Liu Tingyu²,Xue Ting¹²,Chen Xiaofeng⁸,Li Zhiyong¹²^ORCID,An Xin²⁴,Yao Kai¹²,Zhou Fangjian¹²,Han Hui¹²^ORCID

Affiliation:

1. Department of Urology Sun Yat‐sen University Cancer Center Guangzhou China

2. State Key Laboratory of Oncology in South China Collaborative Innovation Centre for Cancer Medicine Guangzhou China

3. Department of Radiology Sun Yat‐sen University Cancer Center Guangzhou China

4. Department of Medical Oncology Sun Yat‐sen University Cancer Center Guangzhou China

5. Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing) Department of Genitourinary Oncology Peking University Cancer Hospital & Institute Beijing China

6. Department of Pathology Sun Yat‐sen University Cancer Center Guangzhou China

7. Department of Genitourinary Oncology H. Lee Moffitt Cancer Center and Research Institute Tampa Florida USA

8. Department of Urology, The First People's Hospital Chenzhou China

Funder

National Natural Science Foundation of China

Publisher

Wiley

Subject

Urology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/bju.15828

Reference44 articles.